Cuu Long Pharmaceutical JSC (HOSE:DCL)

Market Cap	1.70T
Revenue (ttm)	1.31T
Net Income (ttm)	53.57B
Shares Out	73.04M
EPS (ttm)	733.00
PE Ratio	31.79
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	444,300
Average Volume	592,740
Open	20,750
Previous Close	20,600
Day's Range	20,350 - 22,000
52-Week Range	19,000 - 32,000
Beta	0.60
RSI	56.41
Earnings Date	Apr 24, 2025

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company manufactures and distributes pharmaceutical products primarily in Vietnam. The company offers antiallergy, pain reliever and fever reducer, antibiotic, anti-inflammatory, antiviral, cardiovascular, corticosteroid, cough, dermatology, digestive, musculoskeletal, and vitamin and mineral medicines, as well as capsules and medical equipment. It sells its products to hospitals, pharmacies, and drugstores. The company was founded in 1976 and is headquartered in Vinh Long, Vietnam. Cuu Long Pharmaceutical Jo...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 885
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2024, HOSE:DCL's revenue was 1.31 trillion, an increase of 14.24% compared to the previous year's 1.14 trillion. Earnings were 53.57 billion, a decrease of -10.29%.